Autonomix Medical reports preclinical study validating renal nerve sensing platform for physiology-guided denervation

Autonomix Medical disclosed positive preclinical study results on July 24, 2026 for its renal nerve sensing platform.

• Results were presented in the announcement, not flagged for a future conference or publication.
• The study showed the system could detect renal nerve activity, localize targets, then confirm activity changes following ablation.
• The readout supports continued development of physiology-guided renal denervation, aimed at improving procedural precision versus landmark-based approaches.
• The company plans additional preclinical work, then future clinical studies to evaluate the approach in patients.